Users compared with nonusers
|
Nonusers
|
981
|
47,423
|
2.43 (2.06–2.35)
|
Reference
|
Reference
|
Reference
|
Users
|
392
|
13,178
|
2.98 (2.49–3.06)
|
1.38 (1.23–1.55)
|
1.36 (1.21–1.53)
|
1.35 (1.20–1.52)
|
Antidepressant use classified according to duration of use
|
1–30 days
|
37
|
877
|
3.97 (2.70–5.25)
|
2.15 (1.35–3.41)
|
2.12 (1.33–3.36)
|
1.71 (1.10–2.66)
|
31–180 days
|
102
|
3152
|
3.09 (2.49–3.70)
|
1.27 (1.00–1.61)
|
1.25 (1.00–1.59)
|
1.35 (1.06–1.71)
|
181–365 days
|
84
|
2669
|
3.07 (2.41–3.73)
|
1.35 (1.05–1.75)
|
1.33 (1.03–1.72)
|
1.35 (1.05–1.75)
|
366–731 days
|
90
|
3289
|
2.64 (2.10–3.18)
|
1.29 (1.01–1.64)
|
1.27 (1.00–1.62)
|
1.28 (1.01–1.63)
|
> 731 days
|
79
|
3213
|
2.29 (1.56–3.01)
|
1.50 (1.17–1.93)
|
1.48 (1.15–1.91)
|
1.35 (1.05–1.74)
|
Drug class specific analyses (n = 38 concomitant users excluded)
|
Other antidepressant
|
110
|
4465
|
2.24 (1.78–2.71)
|
1.01 (0.83–1.23)
|
0.95 (0.77–1.16)
|
0.94 (0.77–1.15)
|
SSRI
|
246
|
7664
|
2.74 (2.40–3.99)
|
1.32 (1.15–1.52)
|
1.28 (1.11–1.48)
|
1.26 (1.10–1.45)
|
As-treated analyses restricted to the first 180 days
|
Nonusers
|
248
|
9758
|
2.33 (2.03–2.63)
|
Reference
|
Reference
|
Reference
|
Users
|
139
|
4032
|
3.29 (2.74–3.84)
|
1.36 (1.11–1.68)
|
1.31 (1.06–1.62)
|
1.34 (1.08–1.66)
|
Intention-to-treat analyses restricted to the first 180 days
|
Nonusers
|
268
|
10,226
|
2.35 (2.05–2.65)
|
Reference
|
Reference
|
Reference
|
Users
|
173
|
5060
|
3.25 (2.76–3.75)
|
1.31 (1.08–1.58)
|
1.26 (1.03–1.53)
|
1.34 (1.10–1.64)
|